PotBotics: Meshing Science, Tech, Weed and Robotics
How much medical marijuana should people consume and what's it really doing to their brains? Potbotics found a way to combine robotics, technology, weed and science to create the "Potbot" and the "Brainbot." CNBC's Dina Gusovsky reports.
Crain's New York | Tuesday, April 21 2015
New York's Strict Legal Pot Laws Favor High-Tech Entrepreneurs. Got PotBot?
New York's medical-marijuana law, considered among the most restrictive in the country, has drawn criticism from entrepreneurs who say it will stifle development. David Goldstein isn't among the critics - "New York has a rather stringent approach, which PotBotics is positioned to both accommodate and elevate."
High Times | Wednesday, September 24 2014
BrainBot Beta in San Francsisco with High Times Magazine
Mike Sager of Esquire Magazine tests marijuana's effect on his brain with BrainBot Beta, a wireless EEG device that allows general practitioners to capture brain waves and analyze a patient's neural response to cannabinoid stimulants so that the right strain & cannabinoid level can be recommended.
WPix 11 | Monday, February 23 2015
PotBot on WPIX 11
David Goldstein, Co-Founder at PotBotics, discusses PotBot's features and the future of the cannabis industry with WPix 11 morning news.
Medical Marijuana Innovation Through Biotechnology
Our mission is to elevate the cannabis industry to higher medical standards by streamlining the prescription, cultivation and consumer cannabis selection process.
While others are looking to make marijuana stronger, PotBotics is looking to make it smarter. Our diverse technology offering blends robotics, artificial intelligence, DNA analysis and cannabis research to address the major pain points in the medical marijuana industry, benefiting patients, physicians, cultivators and dispensary owners. Together our three products create an enterprise technology platform for medical marijuana. Our “cannabinoid matrixes,” or specific ratios of the various chemicals in marijuana, form the underlying basis of our three main products – PotBot, BrainBot and NanoPot.
Educating Patients Through Our Virtual Budtender
PotBot is a unique medical marijuana recommendation engine that uses cutting edge neural-net algorithms to recommend cannabinoid levels and custom strains to medical marijuana patients. By combining scientific data and crowdsourced reviews, PotBot’s desktop and mobile app will guide patients toward the appropriate strain and consumption method for their specific ailments, eliminating the need for patients to experiment with different strains themselves. With Potbot’s interactive in-store kiosks, dispensaries benefit from a fully integrated POS system, facial recognition, and encrypted cloud infrastructure that help elevate security, meet state regulations, and expedite orders.
Personalizing Medical Marijuana Recommendation
Doctors who understand the medicinal value of cannabis are frustrated by the lack of research and scientific data on medical marijuana and its use cases for treating specific symptoms and conditions. With BrainBot, PotBotics has developed a wireless EEG (electroencephalography) helmet that allows general practitioners to capture brain waves and analyze a patient’s neural response to cannabinoid stimulants so that the right strain and cannabinoid level can be recommended. By identifying and quantifying the effects different cannabinoids have on a patient, BrainBot reduces patients’ reliance on a “roll of the dice” medical marijuana recommendation.
Driving Seed Analytics To Optimize Growth
NanoPot is an advanced DNA reader that scans cannabis seeds to optimize growers’ yields. By using gene-radar technology to rapidly and accurately detect genetic fingerprints from cannabis seeds, cannabis cultivators can both understand the seed’s molecular biology and more effectively breed plants that benefit specific ailments. With NanoPot, cultivators get a fully customized growth plan with optimal amounts of irrigation, sunlight, UV films and nano fertilizers to use when growing specific strains and hybrids, reducing their reliance on outdated techniques for maximizing cannabis growth yields.
If you are interested in learning more about investment opportunities with PotBotics, please complete the inquiry form below and a member of our Investor Relations team will follow up with you shortly
Cannibinoid Whitepaper ———————————————————————
The Application of Cannabinoids and Cannabinoid Ratios for Specific Medical Treatments
The use of phytocannabinoids and synthetic cannabinoid compounds is gaining momentum for various medical applications. Research aimed at elucidating the efficacy and mechanisms of action for various cannabinoids is increasingly demonstrating their potential as therapeutics for other difficult to treat diseases such as multiple sclerosis, cancer, and epilepsy. In this whitepaper, we address the most promising cannabinoid compounds as well as their proven efficacy for medical conditions and symptom relief.
2225 E. Bayshore Road, Suite 200
Palo Alto, CA 94303
205 East 42 Street, 14th Floor New York, NY 10017 917.525.2697
Press Inquiries: Evan Nison
Partnership Opportunities: David Goldstein
@2015 PotBotics, Inc. All rights reserved. Potbotics, Potbot, Potbotics Cloud, PotBotics.com, Nanopot, Brainbot are registered trademarks of PotBotics Inc. Terms and conditions, features, support and services subject to change without notice.